On the other hand, Prox1 acts as a tumor suppressor in hematologic malignancies [12], esophageal cancer [13], hepatoma [14], pancreatic cancer [15], [16], breast cancer [17], and carcinomas of the biliary system [18]. This evidence concerns the gene PROX1 and esophageal cancer.